ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Program

ZL-85FA

A development code. Also written as “ZL-85FA tablets”.

Its studies are led by Chengdu Zenitar Biomedical Technology.

Furthest: phase 2, since Dec 30, 20251 company-led study, 1 open or runningNext primary completion: Jun 30, 2028 (phase 2)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Chengdu Zenitar Biomedical Technology11 open or runningphase 2since Dec 30, 2025Dec 30, 2025Jun 30, 2028phase 2 · NCT07339748

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Dec 30, 2025First study: phase 2 study in Advanced Solid TumorFirst studyNCT07339748 · 51 planned · China

Ahead

  1. Jun 30, 2028Primary completion: phase 2 study in Advanced Solid TumorNCT07339748

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 1 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT07339748Advanced Solid Tumor · China2Not yet recruitingJun 30, 202851

How it is read

Names in the registry

  • “ZL-85FA tablets”, 9 entries

Codes read as this program: ZL85FA.

Conditions, from the studies’ own filings

    First seen by our ledger Nov 13, 2026.

    What this can’t show

    • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
    • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
    • Primary completion dates are the sponsors’ estimates and often move.
    • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.
    ZL-85FA (Chengdu Zenitar Biomedical Technology): development program | ClinicalTrials.gg